Following #HFSA2026, we're keeping the momentum going with JCF's October issue. Discover new research and insights from across the field of #HeartFailure. 📖 Read now: onlinejcf.com/current

🫀 Quadruple guideline-directed medical therapy (GDMT) offers a profound mortality benefit, yet it remains severely underutilized across Heart Failure (HF) care today. Data from HF STATS 2026 reveals only 18% of patients with HFrEF receive all 4 foundational medication pillars.

🥗🥘 About 30%–40% of patients with Heart Failure (HF) live with malnutrition — yet it remains one of the most overlooked challenges in inpatient and outpatient care today. Amanda Vest, MBBS, MPH, FHFSA, explains.

📍A patient’s zip code remains a powerful determinant of Heart Failure (HF) risk, care access, and survival. Our HF STATS 2026 Report highlights a stark geographic divide across the U.S. Click here for the full report bit.ly/3VYt8gO #HFSTATS #HeartFailure #HeartHealth

📈 Heart failure (HF) mortality in the United States has reached a historic peak, reversing more than a decade of prior progress. Read the full report here bit.ly/47oavW8 #HFSTATS #HeartFailure #HeartHealth #HeartHealthy #Healthcare #Cardiology

📌 HF mortality among Black patients stands at 41.7 per 100,000 — more than 3x the rate seen in Asian patients (12.8 per 100,000).

📌 Non-Hispanic Black individuals face the highest age-adjusted HF incidence of any group. 📌 Black adults face 2.4-fold higher age-standardized hospitalization rates than White adults, alongside disproportionate representation across all disease stages (Stage A to D).

🫀Racial and ethnic disparities in heart failure (HF) mortality and hospitalization remain severe, demanding urgent attention across clinical and research communities. Findings from our HF STATS 2026 report highlight a stark reality bit.ly/4s4t8ro

💊 How quickly did practice change after ARIES-HM3? Aspirin use after HM3 fell from 90% in 2023 to 53% in 2025, yet persisted most in patients with vascular disease. Aspirin avoidance showed no excess thromboembolic risk. 💜 #HFSASimPub 🔗 bit.ly/4B5cdJm

🫀 What happens to symptoms after an HF hospitalization? A #HFSA2026 SimPub from our sister journal @JCFINT explores dyspnea trajectories and the need for continued symptom support. Read more: bit.ly/4yLFAPm